FDA approves a second Alzheimer's drug that can modestly slow disease - CNBC TV18
The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the ...
CNBC TV18
15 hours ago